Ambri is looking to expand the potential applications of its critical care diagnostic system, SensiDx System, enabling surgeons to rapidly detect bowel damage that can occur during an operation. [ + ]

Device and diagnostics investment company Premier Bionics is on track to close its initial public offering tomorrow (May 17) oversubscribed. [ + ]

Strengthening its foothold in the US, ResMed has acquired the Californian manufacturing company, Servo Magnetics Inc (SMI) for about $US32 million ($58.38 million). [ + ]

Victoria's government has pledged up to $55,000 in sponsoring industry group AusBiotech's major conference in August. [ + ]

Research institutions are beating a path to the doors of the only two Australian biotechs which supply embryonic stem cells lines meeting current US regulatory requirements. [ + ]

The European Space Agency (ESA) has launched the pioneering Star Tiger project at the Rutherford Appleton Laboratory in England, in which a small team of experts aims to create a terahertz imager operating in two frequencies: 250 and 300 gigahertz.

Clone International has crossed the Tasman in its search for elite dairy bulls. A joint venture agreement has been signed with NZ artificial breeding company Ambreed New Zealand. [ + ]

Sydney-based company Peptech has been issued three divisional applications by the US Patent and Trademarks Office in respect of its TNF antibody patent, bringing the antibody's patent tally to four. [ + ]

Australian research on sugars which stimulate stem cells to become bone tissue has resulted in a biological paste that promotes healing of fractures and breaks. [ + ]

Cardiologists may be prescribing sleep disorder treatments to their patients in the next five years, according to reports from the 14th World Congress of Cardiology, held recently in Sydney. [ + ]

Takara Bio, a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA microarrays, the company announced Tuesday May 14. [ + ]

Melbourne company Stem Cell Sciences has unveiled new commercial laboratories to produce embryonic stem cells and derivative tissue. [ + ]

The Australian Vice-Chancellor's Committee has adopted a wait-and-see attitude following last night's Federal budget. [ + ]

Pouring millions into defence and border security, with cuts in health and welfare, this year's Federal budget carries no significant investment for science and technology. [ + ]

Australia was guilty of resting dangerously on its laurels in relation to testing for mad cow disease, according to a new education foundation. [ + ]